SCHEMBL21795119

SCHEMBL21795119

Clc1ccc(-c2cccc3c2sc2ccccc23)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP14 Q460N5 1/20 0.49
▸ ALOX5 P09917 1/20 0.49
▸ CYP1A2 P05177 3/20 0.45
▸ CYP2A6 P11509 2/20 0.45
▸ GPR3 P46089 1/20 0.43
▸ PRKDC P78527 5/20 0.43
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ PIK3CD O00329 2/20 0.39
▸ PIK3CB P42338 2/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ BRDT Q58F21 1/20 0.39
▸ TYMS P04818 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.37
▸ SLC9A1 P19634 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22457854 0.86 ALOX5 (0.51) PARP14ALOX5CYP1A2CYP2A6GPR3
SCHEMBL16553319 0.85 ALOX5 (0.61) PARP14ALOX5GPR3PRKDCPIK3CD
SCHEMBL22129989 0.84 PARP14 (0.50) PARP14ALOX5CYP1A2CYP2A6GPR3
SCHEMBL12996528 0.83 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCCCNC
SCHEMBL429382 0.83 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCCCNC
SCHEMBL10018846 0.83 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCCCNC
SCHEMBL431845 0.83 ALOX5 (0.59) PARP14ALOX5GPR3PRKDCCCNC
SCHEMBL21616197 0.82 CYP1A2 (0.52) PARP14ALOX5CYP1A2CYP2A6GPR3
SCHEMBL27003700 0.82 PARP14 (0.49) PARP14ALOX5GPR3PRKDCCCNC
SCHEMBL17539967 0.81 PARP14 (0.50) PARP14ALOX5GPR3PRKDCCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220123224-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-21 — — US disclosed
WO-2020045831-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2020-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220123224-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR51E2, OR10J3 PARP14 3918/4885ALOX5 849/4885CYP1A2 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback